| Mrs Janelle Annet Garner, APRN | |
|
9715 Nw 187th Ter, Alachua, FL 32615-6027 | |
| (386) 871-0824 | |
| Not Available |
| Full Name | Mrs Janelle Annet Garner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 9715 Nw 187th Ter, Alachua, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831882281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | APRN11026623 (Florida) | Primary |
| Entity Name | Advanced Wound Ostomy And Continence Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699180240 PECOS PAC ID: 5698991669 Enrollment ID: O20140728002116 |
News Archive
Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.
When studying diseases or testing potential drug therapies, researchers usually turn to cultured cells on Petri dishes or experiments with lab animals, but recently, researchers have been developing a different approach: small, organ-on-a-chip devices that mimic the functions of human organs, serving as potentially cheaper and more effective tools.
Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.
Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.
› Verified 3 days ago
| Entity Name | North Florida Foot & Ankle Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912585878 PECOS PAC ID: 1658773635 Enrollment ID: O20210713003491 |
News Archive
Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.
When studying diseases or testing potential drug therapies, researchers usually turn to cultured cells on Petri dishes or experiments with lab animals, but recently, researchers have been developing a different approach: small, organ-on-a-chip devices that mimic the functions of human organs, serving as potentially cheaper and more effective tools.
Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.
Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Janelle Annet Garner, APRN 9715 Nw 187th Ter, Alachua, FL 32615-6027 Ph: (386) 871-0824 | Mrs Janelle Annet Garner, APRN 9715 Nw 187th Ter, Alachua, FL 32615-6027 Ph: (386) 871-0824 |
News Archive
Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.
When studying diseases or testing potential drug therapies, researchers usually turn to cultured cells on Petri dishes or experiments with lab animals, but recently, researchers have been developing a different approach: small, organ-on-a-chip devices that mimic the functions of human organs, serving as potentially cheaper and more effective tools.
Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.
Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.
› Verified 3 days ago
Rachel Quintana, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10110 Nw County Road 235, Alachua, FL 32615 Phone: 386-462-7346 Fax: 386-462-7381 | |
Mrs. Deena C Dorosheff, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14861 Nw Us Highway 441, Alachua, FL 32615 Phone: 386-462-1911 Fax: 386-462-1943 | |
Mrs. Cami Millicent Cowart, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15260 Nw 147th Dr Ste 100, Alachua, FL 32615 Phone: 386-418-1222 | |
Rachel Emily Cox, MSN, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15652 Nw Us Highway 441, Alachua, FL 32615 Phone: 386-418-4060 | |
Christine Leigh Simmons, MSN, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 765 Turkey Crk, Alachua, FL 32615 Phone: 352-665-5228 | |
Holly Lynn Zarnowiec, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16314 Nw Us Highway 441, Alachua, FL 32615 Phone: 386-518-2418 | |
Dr. Ingrid Allison Bozeman, DNP, APRN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14615 Nw 143rd Pl, Alachua, FL 32615 Phone: 352-275-7825 |